2020-22481. Medicare Program; Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program; Correction  

  • Start Preamble

    AGENCY:

    Centers for Medicare & Medicaid Services (CMS), HHS.

    ACTION:

    Final rule; correction.

    SUMMARY:

    This document corrects technical errors that appeared in the final rule published in the Federal Register on June 2, 2020 entitled “Medicare Program; Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program.”

    DATES:

    Effective date: This correcting document is effective on October 13, 2020.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Cali Diehl, (410) 786-4053 or Christopher McClintick, (410) 786-4682—General Questions.

    Kimberlee Levin, (410) 786-2549—Part C Issues.

    Stacy Davis, (410) 786-7813—Part C and D Payment Issues.

    Melissa Seeley, (212) 616-2329—D-SNP Issues.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    I. Background

    In FR Doc. 2020-11342 of June 2, 2020 (85 FR 33796), there were a number of technical errors that are identified and corrected in this correcting document. The provisions in this correction document are effective as if they had been included in the document published June 2, 2020. Accordingly, the corrections are effective August 3, 2020.

    II. Summary of Errors

    On page 33820, in our discussion of dual eligible special needs plans, we inadvertently included a disclaimer that was not applicable to the published final rule.

    On pages 33876 and 33877, in our discussion of the information collection requirements regarding Special Supplemental Benefits for the Chronically Ill (SSBCI), we inadvertently identified the wrong Paperwork Reduction Act package in our narrative and omitted several Office of Management and Budget (OMB) control numbers from Table 3.

    On page 33881, in our discussion of the information collection requirements regarding medical savings account (MSA) medical loss ratio (MLR), we made inadvertent errors the amount of time it would take beneficiaries to complete an enrollment form.

    On page 33883, in the table that provides a summary of the annual information collection burden (Table 6), we made the following typographical errors:

    • In the table title, we included the term “requirements” instead of “burden”.Start Printed Page 64402
    • In the SSBCI entries there were errors in the identification numbers in the “OMB Control No.” column.
    • In the MSA MLR entries, there were errors in the values and numbers for the “Regulatory citation”, “OMB Control No.”, “Total number of respondents”, and the “Total number of responses”.

    On pages 33889 and 33890, in the table that displays the per-year calculations regarding kidney acquisition costs (Table 11), we made inadvertent errors in the table title (we omitted “s” in the term “costs”). Additionally, on page 33890, the column headings are listed for the years 2013 to 2020 instead of 2021 to 2030.

    III. Waiver of Proposed Rulemaking

    Under 5 U.S.C. 553(b) of the Administrative Procedure Act (APA), the agency is required to publish a notice of the proposed rule in the Federal Register before the provisions of a rule take effect. Similarly, section 1871(b)(1) of the Act requires the Secretary to provide for notice of the proposed rule in the Federal Register and provide a period of not less than 60 days for public comment. In addition, section 553(d) of the APA, and section 1871(e)(1)(B)(i) of the Act mandate a 30-day delay in effective date after issuance or publication of a rule. Sections 553(b)(B) and 553(d)(3) of the APA provide for exceptions from the notice and comment and delay in effective date APA requirements; in cases in which these exceptions apply, sections 1871(b)(2)(C) and 1871(e)(1)(B)(ii) of the Act provide exceptions from the notice and 60-day comment period and delay in effective date requirements of the Act as well. Section 553(b)(B) of the APA and section 1871(b)(2)(C) of the Act authorize an agency to dispense with normal rulemaking requirements for good cause if the agency makes a finding that the notice and comment process are impracticable, unnecessary, or contrary to the public interest. In addition, both section 553(d)(3) of the APA and section 1871(e)(1)(B)(ii) of the Act allow the agency to avoid the 30-day delay in effective date where such delay is contrary to the public interest and an agency includes a statement of support.

    Section 553(d) of the APA ordinarily requires a 30-day delay in effective date of final rules after the date of their publication in the Federal Register. This 30-day delay in effective date can be waived, however, if an agency finds for good cause that the delay is impracticable, unnecessary, or contrary to the public interest, and the agency incorporates a statement of the findings and its reasons in the rule issued.

    We believe that this correcting document does not constitute a rule that would be subject to the notice and comment or delayed effective date requirements of the APA or section 1871 of the Act. This correcting document corrects technical errors in the preamble and regulation text of the final rule but does not make substantive changes to the policies that were adopted in the final rule. As a result, this correcting document is intended to ensure that the information in the final rule accurately reflects the policies adopted in that final rule.

    In addition, even if this were a rule to which the notice and comment procedures and delayed effective date requirements applied, we find that there is good cause to waive such requirements. Undertaking further notice and comment procedures to incorporate the corrections in this document into the final rule or delaying the effective date would be contrary to the public interest because it is in the public's interest to ensure that final rule accurately reflects our policies. Furthermore, such procedures would be unnecessary, as we are not altering payment eligibility or benefit methodologies or policies, but rather, simply implementing correctly the policies that we previously proposed, received comment on, and subsequently finalized. This correcting document is intended solely to ensure that the final rule accurately reflects these policies. Therefore, we believe we have good cause to waive the notice and comment and effective date requirements.

    IV. Correction of Errors

    In FR Doc. 2020-11342 of June 2, 2020 (85 FR 33796), make the following corrections:

    1. On page 33820, lower third of the page, the text box that includes the phrase “DISCLAIMER: Based on the tight time constraints and the need to expedite” is corrected by removing the text box.

    2. On page 33876, lower three-fourths of the page (after the table), second column, sixth full paragraph, lines 6 and 7, the reference to “control number 0938-0763 (CMS-R-262)” is corrected to read “control number 0938-0753 (CMS-R-267)”.

    3. On page 33877, lower third of the page, the table titled “TABLE 3—SUMMARY OF BURDEN FOR SSBCI AT § 422.102” is corrected by correcting the third column (OMB Control No.) for the listed entries (SSBCI provisions) to read as follows:

    ProvisionRegulatory citationOMB Control No.SubjectNumber of respondentsTotal number of responsesTime per response (hr)Total time (hr)Labor cost ($/hr)Annual cost ($)
    SSBCI§ 422.102(f)(3)(i)0938-0753SSBCI: Criteria (Initial Software)2341122808103.3396,717
    SSBCI§ 422.102(f)(3)(i)0938-0753SSBCI: Criteria (Physician review)2341368424193.71,631,729
    SSBCI§ 422.102(f)(3)(i)0938-0753SSBCI: Criteria (Software updates)23415117085.2699,754
    SSBCI§ 422.102(f)(3)(ii)0938-0753Written criteria2341246856.3426,367
    SSBCI§ 422.102(f)(3)(iii)0938-0753Enrollee eligibility23419210686.95179,465

    4. On page 33881, first column, fourth full paragraph, line 8, the phrase “0.5 hours at $25.72/hr” is corrected to read “0.3333 hours at $25.72/hr”

    5. On page 33883, in the table titled “TABLE 6—ANNUAL INFORMATION COLLECTION REQUIREMENTS” the table is corrected by—

    a. Correcting the table title “TABLE 6—ANNUAL INFORMATION COLLECTION REQUIREMENTS” to read “TABLE 6—ANNUAL INFORMATION COLLECTION BURDEN”.

    b. Correcting the second (Regulatory citation), third (OMB Control No.), sixth (Total number of respondents), and seventh columns (Total number of responses) for the listed entry (third row the first MSA MLR provision) to read as follows:Start Printed Page 64403

    ProvisionRegulatory citationOMB Control No.Respondent typeResponse summaryTotal number of respondentsTotal number of responsesTime per response (hr)Total annual time (hr)Labor cost ($/hr)Total annual cost ($)
    MSA MLR§ 422.24400938-NEWEnrolleesMSA MLR: Filling out enrollment forms.2,7652,7650.333392225.7223,705

    c. Correcting the identification numbers in third column (OMB Control No.) for the listed entries (SSBCI provisions) to read as follows:

    ProvisionRegulatory citationOMB Control No.Respondent typeResponse summaryTotal number of respondentsTotal number of responsesTime per response (hr)Total annual time (hr)Labor cost ($/hr)Total annual cost ($)
    SSCBI§ 422.102(f)(3)(i)0938-0753MA PlansSSBCI: Criteria (initial software update)2341122808103.3396,717
    SSCBI§ 422.102(f)(3)(i)0938-0753MA PlansSSBCI: Criteria (Annual physician review)2341368424193.71,631,729
    SSCBI§ 422.102(f)(3)(i)0938-0753MA PlansSSBCI: Criteria (Software updates)23415117085.2699,754
    SSCBI§ 422.102(f)(3)(ii)0938-0753MA PlansSSBCI: Documentation2341246856.3426,367
    SSCBI§ 422.102(f)(3)(iii)0938-0753MA PlansSSBCI: Enrollee records2341970286.9561,039

    d. Correcting the second (Regulatory citation) and seventh columns (Total number of responses) for the listed entries (the specified MSA MLR provisions) to read as follows:

    ProvisionRegulatory citationOMB Control No.Respondent typeResponse summaryTotal number of respondentsTotal number of responsesTime per response (hr)Total annual time (hr)Labor cost ($/hr)Total annual cost ($)
    MSA MLR§ 422.24400938-0753MA PlansMSA MLR: Notify enrollees82,7650.01674677.143,548
    MSA MLR§ 422.24400938-0753MA PlansMSA MLR: Submit to CMS82,7650.01674677.143,548
    MSA MLR§ 422.24400938-0753MA PlansMSA MLR: Archive82,7650.083323036.828,481

    e. Correcting column 2 (Regulatory citation) for the listed entry (the specified MSA MLR provision) to read as follows:

    ProvisionRegulatory citationOMB Control No.Respondent typeResponse summaryTotal number of respondentsTotal number of responsesTime per response (hr)Total annual time (hr)Labor cost ($/hr)Total annual cost ($)
    MSA MLR§ 422.24400938-1252MA PlansMSA MLR: Calculation of the deductible factor880.08330.6664116.3278

    6. On pages 33889 and 33890, in the table titled “Table 11, Per-Year Calculations, Representing the Pre-Statute Baseline Based on Medicare FFS Coverage of Kidney Acquisition Cost”, the table title and table are corrected to read as follows:

    Table 11—Per-Year Calculations, Representing the Pre-Statute Baseline Based on Medicare FFS Coverage of Kidney Acquisition Costs

    20132014201520162017201820192020
    Kidney Acquisition Costs (PMPM):1.721.821.952.082.202.342.492.65
    20212022202320242025202620272028202920302021-2030
    Kidney Acquisition Costs (PMPM):2.823.003.203.403.623.854.104.364.644.94
    Medicare Advantage Enrollment Projection (000's):24,69025,62426,50827,38028,23729,07029,86130,60731,31332,035
    Gross Savings ($Millions):836.2923.51,016.61,117.41,226.31,343.41,468.41,601.71,743.71,898.413,175.6
    Average government share of Gross Savings:83.0%83.0%83.0%83.1%83.2%83.2%83.2%83.4%83.4%83.4%
    Net of Part B Premium:85.6%85.6%85.5%85.4%85.3%85.2%85.0%84.9%84.9%84.9%
    Net Savings ($Millions):594.1655.7721.5792.3869.5951.71,038.91,134.11,235.91,345.69,339.3
    Start Signature
    Start Printed Page 64404

    Dated: October 1, 2020.

    Wilma M. Robinson,

    Deputy Executive Secretary to the Department, Department of Health and Human Services.

    End Signature End Supplemental Information

    [FR Doc. 2020-22481 Filed 10-8-20; 8:45 am]

    BILLING CODE 4120-01-P

Document Information

Effective Date:
10/13/2020
Published:
10/13/2020
Department:
Centers for Medicare & Medicaid Services
Entry Type:
Rule
Action:
Final rule; correction.
Document Number:
2020-22481
Dates:
Effective date: This correcting document is effective on October 13, 2020.
Pages:
64401-64404 (4 pages)
Docket Numbers:
CMS-4190-CN
RINs:
0938-AT97: Contract Year 2021 Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Medicaid, and Medicare Cost Plans (CMS-4190)
RIN Links:
https://www.federalregister.gov/regulations/0938-AT97/contract-year-2021-policy-and-technical-changes-to-the-medicare-advantage-medicare-prescription-drug
PDF File:
2020-22481.Pdf
Supporting Documents:
» Medicare Program: Maximum Out-of-Pocket Limits and Service Category Cost Sharing Standards
» Medicare and Medicaid Programs: Contract Year 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, etc.; Corrections
» Medicare and Medicaid Programs: Contract Year 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly
» Medicare Program: Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program; Correction
» Medicare Program: Contract Year 2021 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program
» Medicare and Medicaid Programs: Contract Year 2021 and 2022 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicaid Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly
» Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Program for Contract Year 2021 (CMS-4190-P)
CFR: (3)
42 CFR 417
42 CFR 422
42 CFR 423